NARI CLASS ACTION: Contact Robbins LLP for Information About the Class Action Against Inari Medical, Inc.

Core Viewpoint - A class action lawsuit has been filed against Inari Medical, Inc. for failing to disclose potential negative impacts on its financial results due to alleged bribes and kickbacks [2] Group 1: Company Overview - Inari Medical, Inc. specializes in developing, manufacturing, and commercializing catheter-based technologies for treating venous thromboembolism (VTE) [1] Group 2: Allegations and Impact - The lawsuit alleges that Inari failed to disclose a civil investigative demand from the U.S. Department of Justice regarding payments to healthcare professionals, which could materially impact its business [2] - Following the disclosure on February 29, 2024, Inari's stock price fell by over $12 per share, or 21%, closing at $46.12 [2] Group 3: Legal Proceedings - Shareholders wishing to serve as lead plaintiffs must file motions by July 12, 2024, and can remain absent class members if they choose not to participate [3]